DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/fwdgw4/smallpox_global) has announced the addition of the "Smallpox Global Clinical Trials Review, H2, 2013" report to their offering.
Smallpox Global Clinical Trials Review, H2, 2013" provides data on the Smallpox clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Smallpox. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Smallpox.
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes /
Hospitals or Companies
Top Companies Participating in Smallpox Therapeutics Clinical Trials
- Bavarian Nordic A/S
- SIGA Technologies, Inc.
- Cangene Corporation
- Chimerix, Inc.
- Sanofi Pasteur, Inc.
- VaxGen, Inc. (Inactive)
- DynPort Vaccine Company LLC
For more information visit http://www.researchandmarkets.com/research/fwdgw4/smallpox_global